<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:24.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:13.5pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
h4
{mso-style-priority:9;
mso-style-link:"Heading 4 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading4Char
{mso-style-name:"Heading 4 Char";
mso-style-priority:9;
mso-style-link:"Heading 4";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;
font-style:italic;}
span.EmailStyle23
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Electrifying news about a new treatment being trialed.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> fyi-prostate-info@googlegroups.com [mailto:fyi-prostate-info@googlegroups.com] <b>On Behalf Of </b>rochab2@gmail.com<br><b>Sent:</b> November 19, 2015 8:26 AM<br><b>To:</b> FYI Prostate Info<br><b>Subject:</b> FYI From smh.com.au Topic: Prostate cancer patients zapped with electricity in new treatment<o:p></o:p></span></p></div><p class=MsoNormal><o:p> </o:p></p><div><h1>Prostate cancer patients zapped with electricity in new treatment <o:p></o:p></h1><div><p class=MsoNormal>Date<o:p></o:p></p><p class=MsoNormal style='margin-left:36.0pt'>November 18, 2015 <o:p></o:p></p></div><div><div><div><p class=MsoNormal><a href="http://www.smh.com.au/national/by/Harriet-Alexander"><span style='text-decoration:none'><img border=0 id="_x0000_i1025" src="http://www.smh.com.au/content/dam/images/g/i/i/u/q/7/image.imgtype.thumbnail.90x90.png/1441797207570.jpg" alt="Harriet Alexander"></span></a><o:p></o:p></p></div><h3><a href="http://www.smh.com.au/national/by/Harriet-Alexander">Harriet Alexander</a> <o:p></o:p></h3><h4>Health Reporter<o:p></o:p></h4></div></div><p class=MsoNormal style='background:white'><span style='color:black'> <o:p></o:p></span></p><p style='background:white'><span style='color:black'>"The electricity is so powerful they have to be paralysed while we're doing it or they would just jump off the table."<o:p></o:p></span></p><p style='background:white'><span style='color:black'>This was St Vincent's Private Hospital urologist Phillip Stricker, speaking of an emerging treatment for prostate cancer that involves zapping the tumour with more electricity than a bolt of lightning.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>Patient Rob Gunn, 65, was unconscious on the operating table, legs aloft, with four needles framing the site of the cancer.<o:p></o:p></span></p><div><p class=MsoNormal style='background:white'><span style='color:black'><img border=0 id="_x0000_i1026" src="http://www.smh.com.au/content/dam/images/g/l/2/6/e/a/image.related.articleLeadwide.620x349.gl1ybg.png/1447888702386.jpg" alt=""You can't underestimate the potential of this technology," says Professor Stricker."><o:p></o:p></span></p><p style='background:white'><span style='color:black'>"You can't underestimate the potential of this technology," says Professor Stricker. <cite>Photo: Steven Siewert</cite> <o:p></o:p></span></p></div><p style='background:white'><span style='color:black'>When the doctors switched on the machine, his legs began to jerk.<o:p></o:p></span></p><div id=adspot-300x250-pos3><p class=MsoNormal style='background:white'><span style='font-size:10.0pt;color:black'>Advertisement</span><span style='color:black'> <o:p></o:p></span></p></div><p style='background:white'><span style='color:black'>Over the next 10 minutes, 90 pulses of electricity passed between the needles, exposing each centimetre of tissue to up to 1500 volts. By the end, the lesion had completely disappeared. <o:p></o:p></span></p><p style='background:white'><span style='color:black'>"You can't underestimate the potential of this technology," Professor Stricker said.<br>"It's going to save a lot of people from having unnecessary surgery."<o:p></o:p></span></p><p class=MsoNormal style='background:white'><span style='color:black'><br> <o:p></o:p></span></p><p style='background:white'><span style='color:black'>The technology is known as the "nanoknife".<o:p></o:p></span></p><p style='background:white'><span style='color:black'>Traditional methods of treating prostate cancer, which attack the whole prostate with radiation or surgery, often come at the cost of the patient's continence or erectile function.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>The nanoknife targets only the site of the cancer, destroying the cells of the cancer without the structures surrounding it, including the erectile and urethral nerves.<o:p></o:p></span></p><div><p class=MsoNormal style='background:white'><span style='color:black'><img border=0 id="_x0000_i1027" src="http://www.smh.com.au/content/dam/images/g/l/2/6/d/a/image.related.articleLeadNarrow.300x0.gl1ybg.png/1447888702386.jpg" alt="The "nanoknife" technique targets only the lesion, framed with four needles in the scrotum."><o:p></o:p></span></p><p style='background:white'><span style='color:black'>The "nanoknife" technique targets only the lesion, framed with four needles in the scrotum.<cite> Photo: Steven Siewert</cite> <o:p></o:p></span></p></div><p style='background:white'><span style='color:black'>Urologists in three countries are trialling the technology on patients who have a single site of localised prostate cancer that needs more treatment than active surveillance.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>About 15 to 20 per cent of prostate cancer patients are suitable for the treatment.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>But Professor Stricker is the first to publish his results on cancer outcomes with a study in <em>Prostate Cancer and Prostatic Diseases</em>, demonstrating that in a study of 25 patients, in 76 per cent of cases the cancer had not returned after eight months.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>None of them developed incontinence or impotence.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>Urological Society of Australia and New Zealand president Mark Frydenberg said he was pleased Australia was at the forefront of prostate research, but it was early days to be claiming victory.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>"This is the first study anywhere in the world that has identified any pathological outcomes from the treatment and we're talking about a relatively small number of patients, so it's a little hard to be jumping to conclusions," Professor Frydenberg said.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>"Really, the success of a treatment depends on long-term outcomes with regard to both safety and cancer outcomes and we don't really have either of those."<o:p></o:p></span></p><p style='background:white'><span style='color:black'>Neither does the operation come cheap.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>Still in experimental days, it does not attract a Medicare rebate or private health insurance subsidy.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>Mr Gunn paid about $30,000 including time off work and travel costs. His medical expenses were just under $15,000. But going into the operation, he could not stop smiling.<o:p></o:p></span></p><p style='background:white'><span style='color:black'>"This is really, really good," he said. "This is a fantastic alternative to having a prostate removed."<o:p></o:p></span></p><p class=MsoNormal style='background:white'><span style='color:black'><br><a href="url:http://www.smh.com.au/national/health/prostate-cancer-patients-zapped-with-electricity-in-new-treatment-20151118-gl1ybg.html">url:http://www.smh.com.au/national/health/prostate-cancer-patients-zapped-with-electricity-in-new-treatment-20151118-gl1ybg.html</a><a href="http://www.smh.com.au/national/health/prostate-cancer-patients-zapped-with-electricity-in-new-treatment-20151118-gl1ybg.html#ixzz3rwYWQTNi"><span style='color:#003399'> </span></a><o:p></o:p></span></p></div><p class=MsoNormal>-- <br>You received this message because you are subscribed to the Google Groups "FYI Prostate Info" group.<br>To unsubscribe from this group and stop receiving emails from it, send an email to <a href="mailto:fyi-prostate-info+unsubscribe@googlegroups.com">fyi-prostate-info+unsubscribe@googlegroups.com</a>.<br>To post to this group, send email to <a href="mailto:fyi-prostate-info@googlegroups.com">fyi-prostate-info@googlegroups.com</a>.<br>To view this discussion on the web visit <a href="https://groups.google.com/d/msgid/fyi-prostate-info/499f7ca3-6466-4761-8f4e-9fab3ac03889%40googlegroups.com?utm_medium=email&utm_source=footer">https://groups.google.com/d/msgid/fyi-prostate-info/499f7ca3-6466-4761-8f4e-9fab3ac03889%40googlegroups.com</a>.<br>For more options, visit <a href="https://groups.google.com/d/optout">https://groups.google.com/d/optout</a>.<o:p></o:p></p></div></body></html>